Literature DB >> 10344008

The Gordon Wilson Lecture. From basic virology to human gene therapy.

K I Berns1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10344008      PMCID： PMC2194317     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  20 in total

1.  Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector.

Authors:  F Palombo; A Monciotti; A Recchia; R Cortese; G Ciliberto; N La Monica
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus.

Authors:  J G Flannery; S Zolotukhin; M I Vaquero; M M LaVail; N Muzyczka; W W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

3.  Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA.

Authors:  E Lusby; K H Fife; K I Berns
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

4.  Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide.

Authors:  E Mendelson; J P Trempe; B J Carter
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

5.  Positive and negative autoregulation of the adeno-associated virus type 2 genome.

Authors:  M A Labow; P L Hermonat; K I Berns
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Site-specific integration by adeno-associated virus.

Authors:  R M Kotin; M Siniscalco; R J Samulski; X D Zhu; L Hunter; C A Laughlin; S McLaughlin; N Muzyczka; M Rocchi; K I Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants.

Authors:  P L Hermonat; M A Labow; R Wright; K I Berns; N Muzyczka
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

8.  Replication of adeno-associated virus DNA. Complementation of naturally occurring rep- mutants by a wild-type genome or an ori- mutant and correction of terminal palindrome deletions.

Authors:  P Senapathy; J D Tratschin; B J Carter
Journal:  J Mol Biol       Date:  1984-10-15       Impact factor: 5.469

9.  Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults.

Authors:  H D Mayor; S Drake; J Stahmann; D M Mumford
Journal:  Am J Obstet Gynecol       Date:  1976-09-01       Impact factor: 8.661

10.  The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells.

Authors:  M A Labow; K I Berns
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103
View more
  2 in total

1.  Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

Authors:  Qiuhong Li; Rehae Miller; Ping-Yang Han; Jijing Pang; Astra Dinculescu; Vince Chiodo; William W Hauswirth
Journal:  Mol Vis       Date:  2008-09-24       Impact factor: 2.367

2.  Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.

Authors:  Wensheng Li; Fansheng Kong; Xia Li; Xufeng Dai; Xiaoqiang Liu; Qinxiang Zheng; Ronghan Wu; Xiangtian Zhou; Fan Lü; Bo Chang; Qiuhong Li; William W Hauswirth; Jia Qu; Ji-Jing Pang
Journal:  Mol Vis       Date:  2009-02-06       Impact factor: 2.367
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.